Trial Profile
A Randomized, Double-Blind, Crossover, Phase IIa Study Comparing a Single-Application TPM/Oxycodone Patch versus Vehicle Patch in the Topical Treatment of Patients with Postherpetic Neuralgia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2022
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Postherpetic neuralgia
- Focus Proof of concept; Therapeutic Use
- Sponsors Phosphagenics
- 17 May 2016 Status changed from recruiting to completed, as reported in a Phosphagenics media release.
- 29 Jan 2016 Primary endpoint (Change from baseline of average pain intensity scores assessed using NPRS between Treatment Period 1 and Treatment Period 2 at 24 hours and 72 hours) has not been met, as per Phosphagenics media release.
- 29 Jan 2016 Results published in Phosphagenics media release.